Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization

Abstract

As compared with paclitaxel-eluting stents, the use of sirolimus-eluting stents results in fewer major adverse cardiac events, primarily by decreasing the rates of clinical and angiographic restenosis.